Assenagon Asset Management S.A. Purchases 40,447 Shares of Kenvue Inc. (NYSE:KVUE)

Assenagon Asset Management S.A. boosted its holdings in Kenvue Inc. (NYSE:KVUE - Free Report) by 4.8% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 884,348 shares of the company's stock after acquiring an additional 40,447 shares during the quarter. Assenagon Asset Management S.A.'s holdings in Kenvue were worth $21,207,000 at the end of the most recent quarter.

A number of other institutional investors also recently added to or reduced their stakes in the business. Fulton Bank N.A. raised its stake in shares of Kenvue by 0.6% in the 1st quarter. Fulton Bank N.A. now owns 78,888 shares of the company's stock worth $1,892,000 after buying an additional 465 shares in the last quarter. White Pine Capital LLC grew its holdings in Kenvue by 1.0% during the fourth quarter. White Pine Capital LLC now owns 54,572 shares of the company's stock worth $1,165,000 after acquiring an additional 542 shares during the period. Deseret Mutual Benefit Administrators raised its position in Kenvue by 29.0% in the fourth quarter. Deseret Mutual Benefit Administrators now owns 2,528 shares of the company's stock worth $54,000 after acquiring an additional 568 shares in the last quarter. SRS Capital Advisors Inc. raised its position in Kenvue by 67.4% in the fourth quarter. SRS Capital Advisors Inc. now owns 1,418 shares of the company's stock worth $30,000 after acquiring an additional 571 shares in the last quarter. Finally, Keystone Financial Group lifted its holdings in Kenvue by 4.8% in the 4th quarter. Keystone Financial Group now owns 12,736 shares of the company's stock valued at $272,000 after acquiring an additional 578 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company's stock.

Wall Street Analysts Forecast Growth

KVUE has been the topic of several recent research reports. UBS Group lifted their price objective on shares of Kenvue from $24.00 to $25.00 and gave the stock a "neutral" rating in a research note on Friday, May 9th. Redburn Atlantic started coverage on shares of Kenvue in a research report on Thursday, April 10th. They issued a "neutral" rating and a $23.50 price target on the stock. Canaccord Genuity Group increased their price objective on Kenvue from $24.00 to $29.00 and gave the company a "buy" rating in a research report on Wednesday, March 5th. Evercore ISI started coverage on Kenvue in a research note on Monday, March 24th. They set an "in-line" rating and a $25.00 price objective for the company. Finally, Barclays boosted their target price on Kenvue from $22.00 to $23.00 and gave the stock an "equal weight" rating in a research report on Monday, May 12th. Seven investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $25.33.

Kenvue Stock Down 2.7%

Shares of KVUE stock traded down $0.60 on Friday, reaching $21.44. 37,242,399 shares of the company's stock traded hands, compared to its average volume of 16,485,322. The company has a market capitalization of $41.14 billion, a P/E ratio of 40.46, a price-to-earnings-growth ratio of 2.62 and a beta of 0.98. Kenvue Inc. has a 12-month low of $17.67 and a 12-month high of $25.17. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00. The business's 50 day moving average price is $23.02 and its two-hundred day moving average price is $22.52.

Kenvue (NYSE:KVUE - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported $0.24 EPS for the quarter, beating the consensus estimate of $0.23 by $0.01. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. The business had revenue of $3.74 billion during the quarter, compared to analysts' expectations of $3.69 billion. During the same quarter in the previous year, the business posted $0.28 EPS. The firm's quarterly revenue was down 3.9% compared to the same quarter last year. On average, equities analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, May 28th. Investors of record on Wednesday, May 14th were paid a $0.205 dividend. This represents a $0.82 annualized dividend and a yield of 3.82%. The ex-dividend date was Wednesday, May 14th. Kenvue's dividend payout ratio is 149.09%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.